Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding in drug design, making it valuable in creating targeted therapies. Commonly employed in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds, which are prevalent in many bioactive molecules. Also utilized in research settings for the preparation of novel boron-containing compounds with potential therapeutic activity.